Advances with RNAi-Based Therapy for Hepatitis B Virus Infection

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection

Infection with hepatitis B virus (HBV) remains a global health challenge. Approximately 292 million people worldwide are chronically infected with HBV and the annual mortality from the infection is approaching 900,000. Despite the availability of an effective prophylactic vaccine, millions of indivi...

Full description

Bibliographic Details
Main Authors: Fiona van den Berg, Shonisani Wendy Limani, Njabulo Mnyandu, Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Viruses
Subjects:
HBV
RNAi
siRNA
shRNA
miRNA
cccDNA
Online Access:https://www.mdpi.com/1999-4915/12/8/851

Internet

https://www.mdpi.com/1999-4915/12/8/851

Similar Items